These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8742904)

  • 1. 3-D conformal radiotherapy for prostate cancer. The University of Michigan experience.
    Sandler HM
    Front Radiat Ther Oncol; 1996; 29():238-43. PubMed ID: 8742904
    [No Abstract]   [Full Text] [Related]  

  • 2. 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center.
    Leibel SA; Kutcher GJ; Zelefsky MJ; Burman CM; Mohan R; Ling CC; Fuks Z
    Front Radiat Ther Oncol; 1996; 29():229-37. PubMed ID: 8742903
    [No Abstract]   [Full Text] [Related]  

  • 3. When should the seminal vesicles be included in the target volume in prostate radiotherapy?
    Bayman NA; Wylie JP
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):302-7. PubMed ID: 17448647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
    Zelefsky MJ; Marion C; Fuks Z; Leibel SA
    J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
    Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Albertsen PC
    J Urol; 2005 Nov; 174(5):1969-70. PubMed ID: 16217368
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-institution results of primary external-beam radiation for the treatment of t1-t3 prostate cancer.
    Weiss W; Horninger W; Forthuber BC; Ulmer H; Lukas P; Sweeney RA
    Strahlenther Onkol; 2007 Jun; 183(6):321-6. PubMed ID: 17520186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity.
    Pollack A; Zagars GK; Rosen II
    Semin Oncol; 1999 Apr; 26(2):150-61. PubMed ID: 10597726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal toxicity with 3-FAT radiotherapy of prostate cancer.
    Weil MD; Crawford ED; Cornish P; Dzingle W; Stuhr K; Pickett B; Roach M
    Semin Urol Oncol; 2000 May; 18(2):127-32. PubMed ID: 10875453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
    Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
    Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
    Zelefsky MJ; Chan H; Hunt M; Yamada Y; Shippy AM; Amols H
    J Urol; 2006 Oct; 176(4 Pt 1):1415-9. PubMed ID: 16952647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Constraints and dosage for prostate cancer patients treated with conformal radiotherapy and intensity modulated radiation therapy].
    Chauvet I; Gaboriaud G; Pontvert D; Zefkili S; Giraud P; Rosenwald JC; Cosset JM
    Cancer Radiother; 2004 Dec; 8(6):337-51. PubMed ID: 15619378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMRT for the treatment of prostate cancer: a comparison of a forward-planned technique and an inverse-planned technique utilizing a dose gradient method.
    Edlund T; Zimmer JR; Gannett DE
    Med Dosim; 2004; 29(2):128-33. PubMed ID: 15191762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
    W V Med J; 2005; 101(4):168-71. PubMed ID: 16296198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.